Document is current
Any future updates will be listed below
-
Authors
Karikari, Thomas K.
Benedet, Andréa L.
Ashton, Nicholas J.
Lantero Rodriguez, Juan
Snellman, Anniina https://orcid.org/0000-0001-6191-0954
Suárez-Calvet, Marc https://orcid.org/0000-0002-2993-569X
Saha-Chaudhuri, Paramita https://orcid.org/0000-0003-1987-320X
Lussier, Firoza
Kvartsberg, Hlin
Rial, Alexis Moscoso https://orcid.org/0000-0003-0170-036X
Pascoal, Tharick A.
Andreasson, Ulf
Schöll, Michael https://orcid.org/0000-0001-7800-1781
Weiner, Michael W.
Rosa-Neto, Pedro
Trojanowski, John Q.
Shaw, Leslie M.
Blennow, Kaj https://orcid.org/0000-0002-1890-4193
Zetterberg, Henrik https://orcid.org/0000-0003-3930-4354
,
- License Information
-
More Information
Article History
Received: 1 July 2020
Revised: 1 October 2020
Accepted: 8 October 2020
First Online: 26 October 2020
Compliance with ethical standards
:
: KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers. HZ has served at scientific advisory boards for Wave, Samumed, CogRx, Siemens Healthineers, and Roche Diagnostics and has given open lectures for Alzecure, Fujirebio, and Biogen. HZ and KB are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. The other authors declare no competing interests.
